annual cash & cash equivalents:
$313.49M+$60.29M(+23.81%)Summary
- As of today (August 22, 2025), ELVN annual cash & cash equivalents is $313.49 million, with the most recent change of +$60.29 million (+23.81%) on December 31, 2024.
- During the last 3 years, ELVN annual cash & cash equivalents has risen by +$203.47 million (+184.93%).
- ELVN annual cash & cash equivalents is now at all-time high.
Performance
ELVN Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$490.50M+$200.95M(+69.40%)Summary
- As of today (August 22, 2025), ELVN quarterly cash & cash equivalents is $490.50 million, with the most recent change of +$200.95 million (+69.40%) on June 30, 2025.
- Over the past year, ELVN quarterly cash & cash equivalents has increased by +$178.06 million (+56.99%).
- ELVN quarterly cash & cash equivalents is now at all-time high.
Performance
ELVN quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ELVN Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.8% | +57.0% |
| 3 y3 years | +184.9% | +712.9% |
| 5 y5 years | +984.5% | +361.5% |
ELVN Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +255.4% | at high | +771.2% |
| 5 y | 5-year | at high | +984.5% | at high | +771.2% |
| alltime | all time | at high | +4146.7% | at high | +771.2% |
ELVN Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $490.50M(+69.4%) |
| Mar 2025 | - | $289.56M(-7.6%) |
| Dec 2024 | $313.49M(+23.8%) | $313.49M(+7.4%) |
| Sep 2024 | - | $291.89M(-6.6%) |
| Jun 2024 | - | $312.44M(-2.5%) |
| Mar 2024 | - | $320.56M(+26.6%) |
| Dec 2023 | $253.20M(+187.1%) | $253.20M(-3.9%) |
| Sep 2023 | - | $263.48M(-5.2%) |
| Jun 2023 | - | $277.87M(-4.9%) |
| Mar 2023 | - | $292.10M(+231.2%) |
| Dec 2022 | $88.20M | $88.20M(+56.6%) |
| Sep 2022 | - | $56.30M(-6.7%) |
| Jun 2022 | - | $60.34M(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $72.90M(-19.2%) |
| Dec 2021 | $110.02M(+24.7%) | - |
| Dec 2021 | - | $90.28M(-12.2%) |
| Sep 2021 | - | $102.84M(+54.0%) |
| Jun 2021 | - | $66.77M(-11.7%) |
| Mar 2021 | - | $75.59M(-14.3%) |
| Dec 2020 | $88.22M(+205.2%) | $88.22M(-8.2%) |
| Sep 2020 | - | $96.09M(-9.6%) |
| Jun 2020 | - | $106.28M(+0.4%) |
| Mar 2020 | - | $105.87M |
| Dec 2019 | $28.91M(+291.6%) | - |
| Dec 2018 | $7.38M(-23.7%) | - |
| Dec 2017 | $9.67M | - |
FAQ
- What is Enliven Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Enliven Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ELVN is $313.49M
What is the all time high annual cash & cash equivalents for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual cash & cash equivalents is $313.49M
What is Enliven Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ELVN annual cash & cash equivalents has changed by +$60.29M (+23.81%)
What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ELVN is $490.50M
What is the all time high quarterly cash & cash equivalents for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $490.50M
What is Enliven Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ELVN quarterly cash & cash equivalents has changed by +$178.06M (+56.99%)